Novel AChE and ROCK dual inhibitor designed for Alzheimer's disease therapy promotes neurodifferentiation and neuritogenesis in SHSY5Y cells (2022)
- Authors:
- USP affiliated authors: MOREIRA, NATALIA CHERMONT DOS SANTOS - FMRP ; LIMA, JÉSSICA ELLEN BARBOSA DE FREITAS - FMRP ; CARVALHO, IVONE - FCFRP ; HOJO, ELZA TIEMI SAKAMOTO - FFCLRP ; TAMAROZZI, ELVIRA REGINA - EACH ; PIASSI, LARISSA DE OLIVEIRA - FMRP
- Unidades: FMRP; FCFRP; FFCLRP; EACH
- DOI: 10.1002/em.22502
- Subjects: DOENÇA DE ALZHEIMER; NEURÔNIOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Environmental and Molecular Mutagenesis
- ISSN: 0893-6692
- Volume/Número/Paginação/Ano: v. 63, n. S1, p. 106-107, res. PS25, 2022
- Conference titles: International Conference on Environmental Mutagens
- Este artigo NÃO possui versão em acesso aberto
-
Status: Nenhuma versão em acesso aberto identificada -
ABNT
MOREIRA, Natália Chermont dos Santos et al. Novel AChE and ROCK dual inhibitor designed for Alzheimer's disease therapy promotes neurodifferentiation and neuritogenesis in SHSY5Y cells. Environmental and Molecular Mutagenesis. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/em.22502. Acesso em: 15 mar. 2026. , 2022 -
APA
Moreira, N. C. dos S., Tamarozzi, E. R., Piassi, L. de O., Lima, J. E. B. de F., Carvalho, I., & Sakamoto-Hojo, E. T. (2022). Novel AChE and ROCK dual inhibitor designed for Alzheimer's disease therapy promotes neurodifferentiation and neuritogenesis in SHSY5Y cells. Environmental and Molecular Mutagenesis. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1002/em.22502 -
NLM
Moreira NC dos S, Tamarozzi ER, Piassi L de O, Lima JEB de F, Carvalho I, Sakamoto-Hojo ET. Novel AChE and ROCK dual inhibitor designed for Alzheimer's disease therapy promotes neurodifferentiation and neuritogenesis in SHSY5Y cells [Internet]. Environmental and Molecular Mutagenesis. 2022 ; 63( S1): 106-107.[citado 2026 mar. 15 ] Available from: https://doi.org/10.1002/em.22502 -
Vancouver
Moreira NC dos S, Tamarozzi ER, Piassi L de O, Lima JEB de F, Carvalho I, Sakamoto-Hojo ET. Novel AChE and ROCK dual inhibitor designed for Alzheimer's disease therapy promotes neurodifferentiation and neuritogenesis in SHSY5Y cells [Internet]. Environmental and Molecular Mutagenesis. 2022 ; 63( S1): 106-107.[citado 2026 mar. 15 ] Available from: https://doi.org/10.1002/em.22502 - Novel dual AChE and ROCK2 inhibitor induces neurogenesis via PTEN/AKT pathway in Alzheimer’s disease model
- Novel hybrid acetylcholinesterase inhibitors induce differentiation and neuritogenesis in neuronal cells in vitro through activation of the AKT pathway
- Effects of y-27632, a rho-kinase (rock) inhibitor, in the neurodifferentiation of sh-sy5y human neuroblastoma cell line
- PARP-1 inhibition does not protect neuronal-like and primary neural progenitor cells against in vitro induced-oxidative damage
- Mechanisms underlying the pathophysiology of type 2 diabetes: from risk factors to oxidative stress, metabolic dysfunction, and hyperglycemia
- Oxidative stress, DNA damage, and transcriptional expression of DNA repair and stress response genes in diabetes mellitus
- Neuroprotective effects of cholinesterase inhibitors: current scenario in therapies for Alzheimer’s disease and future perspectives
- NRF2 activation as a potential strategy to enhance neuronal survival under the exposure to oxidative stress
- Neuroprotective effect of acetylcholinesterase inhibitors in response to oxidative stress in neuronal SH-SY5Y cell line
- Brain organoids as a neuronal model applied in neuroscience and neurodegenerative diseases
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003278283.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
